Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.58 $5.85 Friday, 10th May 2024 CTMX stock ended at $1.98. This is 2.94% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 10.81% from a day low at $1.85 to a day high of $2.05.
90 days $1.38 $5.85
52 weeks $1.04 $5.85

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
Apr 07, 2022 $2.82 $2.85 $2.76 $2.77 664 000
Apr 06, 2022 $2.73 $2.87 $2.67 $2.83 520 800
Apr 05, 2022 $2.89 $2.91 $2.75 $2.77 575 400
Apr 04, 2022 $2.81 $3.02 $2.81 $2.89 795 100
Apr 01, 2022 $2.69 $2.81 $2.62 $2.81 724 245
Mar 31, 2022 $2.75 $2.79 $2.65 $2.67 632 085
Mar 30, 2022 $2.82 $2.91 $2.75 $2.77 605 992
Mar 29, 2022 $2.73 $2.88 $2.73 $2.83 1 202 900
Mar 28, 2022 $2.75 $2.75 $2.57 $2.67 754 400
Mar 25, 2022 $2.97 $2.97 $2.67 $2.69 1 829 400
Mar 24, 2022 $2.90 $3.00 $2.84 $2.95 1 025 500
Mar 23, 2022 $2.99 $3.01 $2.82 $2.88 1 828 600
Mar 22, 2022 $3.12 $3.12 $2.96 $3.00 2 788 091
Mar 21, 2022 $3.17 $3.24 $3.08 $3.09 879 289
Mar 18, 2022 $3.39 $3.57 $3.19 $3.21 4 314 962
Mar 17, 2022 $3.01 $3.47 $3.00 $3.47 1 409 100
Mar 16, 2022 $3.05 $3.11 $2.94 $3.00 2 093 700
Mar 15, 2022 $3.14 $3.15 $2.96 $2.98 865 400
Mar 14, 2022 $3.55 $3.57 $3.12 $3.13 972 100
Mar 11, 2022 $3.84 $3.84 $3.55 $3.56 670 800
Mar 10, 2022 $3.94 $3.97 $3.70 $3.81 468 300
Mar 09, 2022 $3.93 $4.08 $3.82 $4.00 677 600
Mar 08, 2022 $3.77 $3.96 $3.60 $3.81 352 100
Mar 07, 2022 $3.77 $3.83 $3.69 $3.76 456 200
Mar 04, 2022 $3.76 $3.86 $3.68 $3.71 540 600
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT